Head-to-head · free
Intuitive Surgical, Inc. vs Kyntra Bio, Inc.
ISRG vs KYNB — return on capital, cash generation, margins and balance sheet side by side.
ISRG
5 / 6
measures where ISRG leads
KYNB
1 / 6
measures where KYNB leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | ISRG · FY2025 | KYNB · FY2025 |
|---|---|---|
| Revenue | $10.1B | $6.4M |
| Net income | $2.9B | $183.5M |
| Revenue growth (yearly, multi-year) | 67.1% | -59.3% |
| Free cash flow | — | (4.8M) |
| Free cash flow margin | — | -74.7% |
| Net cash / (debt) | — | — |
| ROIC | 14.8% | — |
| Return on equity | 16.7% | — |
| Gross margin | 66.0% | 91.4% |
| Operating margin | 29.3% | -704.1% |
| Net debt / EBITDA | -0.93x | 1.06x |
Figures are as reported by each company; latest fiscal year shown.
Where Intuitive Surgical, Inc.'s cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Kyntra Bio, Inc.'s cash went (FY2025)
- Capital spending
- $38000
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free